Document and Entity Information |
6 Months Ended |
|---|---|
Jun. 30, 2023 | |
| Entity Addresses [Line Items] | |
| Entity Registrant Name | Vertical Aerospace Ltd. |
| Entity Central Index Key | 0001867102 |
| Document Type | 6-K |
| Document Period End Date | Jun. 30, 2023 |
| Current Fiscal Year End Date | --12-31 |
| Document Fiscal Year Focus | 2023 |
| Document Fiscal Period Focus | Q2 |
| Amendment Flag | false |
Unaudited Condensed Consolidated Interim Statements of Income and Comprehensive Income - GBP (£) £ in Thousands |
6 Months Ended | |
|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
|
| Unaudited Condensed Consolidated Interim Statements of Income and Comprehensive Income | ||
| Research and development expenses | £ (27,500) | £ (19,396) |
| Administrative expenses | (24,266) | (23,466) |
| Related party administrative expenses | (42) | |
| Other operating income | 15,845 | 3,407 |
| Operating loss | (35,963) | (39,455) |
| Finance income | 32,333 | 42,497 |
| Finance costs | (8,140) | (20,063) |
| Total net finance income | 24,193 | 22,434 |
| Loss before tax | (11,770) | (17,021) |
| Net loss for the period | (11,770) | (17,021) |
| Translation differences | (6,922) | 9,482 |
| Total comprehensive loss for the period | £ (18,692) | £ (7,539) |
| Basic loss per share | £ (0.06) | £ (0.10) |
| Diluted loss per share | £ (0.06) | £ (0.10) |
Unaudited Condensed Consolidated Interim Statements of Financial Position - GBP (£) |
Jun. 30, 2023 |
Dec. 31, 2022 |
|---|---|---|
| Non-current assets | ||
| Property, plant and equipment | £ 3,336,000 | £ 2,690,000 |
| Right of use assets | 2,784,000 | 3,121,000 |
| Intangible assets | 1,529,000 | 2,048,000 |
| Non-current assets | 7,649,000 | 7,859,000 |
| Current assets | ||
| Trade and other receivables | 19,727,000 | 18,864,000 |
| Financial assets at amortized cost | 59,886,000 | |
| Restricted cash | 1,700,000 | 1,700,000 |
| Cash and cash equivalents | 89,693,000 | 62,927,000 |
| Current assets | 111,120,000 | 143,377,000 |
| Total assets | 118,769,000 | 151,236,000 |
| Equity | ||
| Share capital | 16,517 | 15,952 |
| Other reserves | 91,168,000 | 94,857,000 |
| Share premium | 257,838,000 | 257,197,000 |
| Accumulated deficit | (352,648,000) | (344,752,000) |
| Total equity | (3,625,000) | 7,318,000 |
| Non-current liabilities | ||
| Lease liabilities | 2,259,000 | 2,645,000 |
| Provisions | 317,000 | 365,000 |
| Derivative financial liabilities | 100,834,000 | 115,247,000 |
| Trade and other payables | 3,933,000 | 4,153,000 |
| Non-current liabilities | 107,343,000 | 122,410,000 |
| Current liabilities | ||
| Lease liabilities | 676,000 | 516,000 |
| Warrant liabilities | 2,727,000 | 4,961,000 |
| Trade and other payables | 11,648,000 | 16,031,000 |
| Current liabilities | 15,051,000 | 21,508,000 |
| Total liabilities | 122,394,000 | 143,918,000 |
| Total equity and liabilities | £ 118,769,000 | £ 151,236,000 |
Unaudited Condensed Consolidated Interim Statements of Changes in Equity - GBP (£) £ in Thousands |
Share capital |
Share premium. |
Other reserves |
Accumulated deficit |
Total |
|---|---|---|---|---|---|
| Equity at beginning of period at Dec. 31, 2021 | £ 16 | £ 248,354 | £ 63,314 | £ (250,123) | £ 61,561 |
| Loss for the period | (17,021) | (17,021) | |||
| Translation differences | 9,482 | 9,482 | |||
| Total comprehensive loss | 9,482 | (17,021) | (7,539) | ||
| Share based payment transactions | 749 | 6,465 | 80 | 7,294 | |
| Reclassification of warrants | 1,010 | 1,010 | |||
| Equity at end of period at Jun. 30, 2022 | 16 | 249,103 | 80,271 | (267,064) | 62,326 |
| Equity at beginning of period at Dec. 31, 2022 | 16 | 257,197 | 94,857 | (344,752) | 7,318 |
| Loss for the period | (11,770) | (11,770) | |||
| Translation differences | (6,922) | (6,922) | |||
| Total comprehensive loss | (6,922) | (11,770) | (18,692) | ||
| Share based payment transactions | 7,107 | 7,107 | |||
| Exercise of Share Options | 1 | 641 | 642 | ||
| Transfer of reserves | (3,874) | 3,874 | |||
| Equity at end of period at Jun. 30, 2023 | £ 17 | £ 257,838 | £ 91,168 | £ (352,648) | £ (3,625) |
General information |
6 Months Ended |
|---|---|
Jun. 30, 2023 | |
| General information | |
| General information | 1General information Vertical Aerospace Ltd (the “Company”, or the “Group” if together with its subsidiaries) is incorporated under the Companies Law (as amended) of the Cayman Islands. The address of its principal executive office is: Unit 1 Camwal Court, Bristol, United Kingdom. The Company’s shares are listed on the New York Stock Exchange. The ultimate controlling party is Stephen Fitzpatrick. These financial statements are presented in pounds sterling and all values are rounded to the nearest thousand (£’000) except when otherwise indicated. These financial statements were approved by the board of directors on July 27, 2023. Principal activities The principal activity of the Company and its wholly owned subsidiary, Vertical Aerospace Group Ltd (“VAGL”), is the development and commercialization of vertical take-off and landing electrically powered aircraft (“eVTOL”). The Group’s main operations are in the United Kingdom. |
Significant accounting policies |
6 Months Ended | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||
| Significant accounting policies | |||||||||||||||||||||||||||||||
| Significant accounting policies | 2Significant accounting policies Basis of preparation This unaudited condensed consolidated interim financial report for the half-year reporting period ended 30 June 2022 has been prepared in accordance with International Financial Reporting Standards (IFRS) applicable to the preparation of interim financial statements, IAS 34 Interim Financial Reporting. The interim report does not include all the notes of the type normally included in an annual financial report. Accordingly, this report is to be read in conjunction with the annual report for the year ended 31 December 2022. The accounting policies adopted are consistent with those of the previous financial year. The unaudited condensed consolidated interim financial report has been prepared on a historical cost basis, as modified by the revaluation of certain financial assets and liabilities (including derivative financial instruments) which are recognized at fair value through profit and loss. Items included in the unaudited condensed consolidated interim financial report are measured using the currency of the primary economic environment in which the entity and its subsidiaries operate (‘the functional currency’). The financial information is presented in pounds sterling (‘£’ or ‘GBP’), which is the Group’s functional and presentation currency, and all amounts are presented in and rounded to the nearest thousand unless otherwise indicated. 2Significant accounting policies (continued) Basis of consolidation Vertical Aerospace Ltd is the parent of the Group. Details of the material subsidiaries are as follows:
All intercompany balances and transactions have been eliminated in consolidation. Significant accounting policies and key accounting estimates The accounting policies adopted are consistent with those of the previous financial year, with the exception of newly adopted policies as discussed below. Revision to comparative period for correction of immaterial error In connection with the preparation of the Group's condensed consolidated financial information for the six months period ended June 30, 2023, an error was identified in relation to the classification of foreign exchange rate changes in the statement of cash flows presented in the condensed consolidated financial information for the six months period ended June 30, 2022. An item of £4.6 million was incorrectly reported in the condensed consolidated statement of cash flows within adjustments to cash flows from non-cash items under Cash flows from operating activities instead of presenting it as effect of foreign exchange rate changes to reconcile the net increase or decrease in cash balances during the period. The correction of this matter will result in an increase in net cash flows used in operating activities of £4.6 million and an increase in effect of foreign exchange rate changes by £4.6 million. The revision has no impact on the condensed consolidated statement of financial position, statement of income and comprehensive income and statement of changes in equity. The Group has evaluated these amounts and has concluded that they should be corrected by revising the previously reported financial information when such amounts are presented for comparative purposes for the six months period ended June 30, 2023. Going concern Management has prepared a cashflow forecast for the Group and has considered the ability for the Group to continue as a going concern for the foreseeable future, being at least 12 months after approving this financial information. The Group is currently in the research and development phase of its journey to commercialize eVTOL technology. Commensurate with being in the development phase, the Group has invested heavily in research to support the development of its aircraft. The Group is not currently generating revenue and has incurred net losses and net cash outflows from operating activities since inception. As of June 30, 2023, the Group had £89.7 million of cash and cash equivalents held by the Company. Within the next 12 months following the date of this report, management expects the funding requirements to be approximately £80 million, which will be used primarily to fund the creation and testing of prototype aircraft. 2Significant accounting policies (continued) The Group will need to raise additional capital to fund its future operations and remain as a going concern, before the Group uses all of its existing resources. There can be no assurance that the Group will be able to obtain additional funding on acceptable terms and thus have sufficient funds to meet Group’s funding requirements. As a result, the timely completion of financing is important for the Group’s ability to continue as a going concern. The dependency on raising additional capital indicates that a material uncertainty exists that may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) on the Group’s ability to continue as a going concern and therefore the Group may be unable to realise the assets and discharge the liabilities in the normal course of business. The consolidated financial statements have been prepared assuming that the Group will continue as a going concern, which contemplates the continuity of operations, realisation of assets and the satisfaction of liabilities in the ordinary course of business and do not include any adjustments that would result if the Group were unable to continue as a going concern. Changes in accounting policy A number of amended standards became applicable for the current reporting period. The group did not have to change its accounting policies or make retrospective adjustments as a result of adopting these amended standards: 1.IFRS 17 Insurance Contracts 2.Disclosure of Accounting Policies – Amendments to IAS 1 and IFRS Practice Statement 2 3.Definition of Accounting Estimates – Amendments to IAS 8 4.Deferred Tax related to Assets and Liabilities arising from a Single Transaction – Amendments to IAS 12 |
Critical accounting judgements and key sources of estimation uncertainty |
6 Months Ended |
|---|---|
Jun. 30, 2023 | |
| Critical accounting judgements and key sources of estimation uncertainty | |
| Critical accounting judgements and key sources of estimation uncertainty | 3Critical accounting judgements and key sources of estimation uncertainty The preparation of the unaudited condensed consolidated interim financial information in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the date of the financial information and the reported amounts of expenses during the reporting period. The Company’s most significant estimates and judgments involve valuation of the Company’s stock-based compensation or consideration, including the fair value of common stock and market-based restricted stock units, in addition to the fair valuation of derivative liabilities. These estimates are based on historical data and experience, as well as various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Such estimates often require the selection of appropriate valuation methodologies and models and may involve significant judgment in evaluating ranges of assumptions and financial inputs. Actual results may differ from those estimates under different assumptions, financial inputs, or circumstances. In preparing these unaudited condensed consolidated interim financial statements, the significant judgements made by management in applying the Group’s accounting policies and the key sources of estimation were the same as those that applied to the consolidated financial statements as at and for the year ended 31 December 2022. |
Other operating income |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||
| Other operating income | |||||||||||||||||||||||||||||||||||||||||
| Other operating income | 4Other operating income The analysis of the Group’s other operating income for the period is as follows:
Government grants The group receives government grants relating to specific research and development activities relating to eVTOL technologies and is recognised in the period to which the expense it is intended to fund relates. The grant is made to fund research and development expenditure and is recognised in profit or loss in the period to which the expense it is intended to fund relates. R&D tax relief The R&D tax relief relates to the research and development tax reliefs provided by the UK Government in support of UK companies working on innovative projects in science and technology. |
Expenses by nature |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Expenses by nature | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Expenses by nature | 5Expenses by nature Included within administrative expenses, research and development expenses and related party administrative expenses are the following expenses.
5Expenses by nature (continued) Staff costs excluding share-based payment expenses relates primarily to salary and salary related expenses, including social security and pension contributions. |
Finance income |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Finance Income. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Finance income | 6Finance income
|
Loss per share |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Loss per share | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Loss per share | 7Loss per share Basic earnings per share, in this case a loss per share, is calculated by dividing the loss for the period attributable to ordinary equity holders of the parent by the number of ordinary shares outstanding. Because a net loss for all period presented has been reported, diluted loss per share is the same as basic loss per share. Therefore, all potentially dilutive common stock equivalents are antidilutive and have been excluded from the calculation of net loss per share. The calculation of loss per share is based on the following data:
|
Trade and other receivables |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||
| Trade and other receivables | |||||||||||||||||||||||||||||||||||||||||
| Trade and other receivables | 8Trade and other receivables
Included within Government receivables is £6,422 thousand for the R&D tax credit receivable (December 31, 2022: £7,212 thousand). |
Share capital and reserves |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share capital and reserves | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share capital and reserves | 9Share capital and reserves Allotted, called up and fully paid shares
Ordinary shares have full voting rights, full dividend rights. The Company is authorised to issue 500,000,000 ordinary shares. Other reserves During the period other reserves increased by £7,107 thousand as a result of share based payment transactions and decreased by £3,874 thousand following exercise of options and other awards to staff. Other reserves also decreased by £6,922 thousand reflecting cumulative translation differences. Nature and purpose of other reserves The share-based payments reserve is used to recognise the grant date fair value of options issued to employees but not exercised. The translation reserve arises as a result of the retranslation of overseas subsidiaries in consolidated financial statements. The warrant reserve is used to recognise the fair value of warrants issued in exchange for a fixed amount of cash or another financial asset for a fixed number of the Company’s ordinary shares (‘fixed-for-fixed condition’). Share Premium On May 3, 2023 a total of 7,000,000 shares were issued, including 6,989,140 shares issued on exercise of options and other awards to staff. Resulting proceeds due totalled of £641 thousand, of which £464 thousand remained unpaid as at June 30, 2023. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trade and other payables |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trade and other payables | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trade and other payables | 10Trade and other payables Amounts falling due within one year:
Amounts falling due after more than one year:
The Group’s exposure to market and liquidity risks, including maturity analysis, related to trade and other payables is disclosed in note 15 Financial risk management and impairment of financial assets. |
Warrant Liability |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Warrant Liability | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Warrant Liability | 11Warrant Liability The following warrants are in issue but not exercised:
Recorded as a liability, the following shows the change in fair value during the period ended June 30, 2023:
Each public warrant entitles the registered holder to purchase one share of common stock at a price of $11.50 per share. Once the public warrants become exercisable, the Company may redeem the public warrants at a price of $0.01 per public warrant if the closing price of the common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period. The public warrants expire on December 15, 2026 or earlier upon redemption or liquidation. |
Share-based payments |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based payments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based payments | 12Share-based payments The Group has established two employee option plans. The EMI Scheme was closed to employees during 2021, and the 2021 Incentive Plan was implemented in 2022. For more information about the option plans, please refer to the Group’s annual financial statements for the year ended December 31, 2022. The total expense recognised by the company during the year in respect of these plans is shown below:
The summary of options granted under the plans were as follows: EMI Scheme
The number of options which were exercisable at June 30, 2023 was 12,463,199 (December 31, 2022: 11,317,247) with exercise prices ranging from £0.04 to £1.15. The expected average remaining vesting period has been determined 2.09 years (December 31, 2022: 2.59 years). 2021 Incentive Plan
12Share-based payments (continued) The number of options which were exercisable at June 30, 2023 was 1,993,248 (December 31, 2022: 1,073,560) with exercise prices ranging of £nil or £6.63. Options exercised during the period related solely to nil-cost options. The expected average remaining vesting period for nil cost options has been determined as 2.59 years and for CSOP options has been determined as 3.21 years. The average exercise price presented above relates to CSOP options only. All options granted during the year were immediately vesting nil cost options. In addition to the above, a total of 18,750 nil cost options were awarded to non-executive directors during the period. The fair value of all options granted during the period has been determined with reference to the share price at grant date. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative financial liabilities |
6 Months Ended | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||
| Derivative financial liabilities | |||||||||||||||||||||||||
| Derivative financial liabilities | 13Derivative financial liabilities Convertible Senior Secured Notes consists of the following:
On December 16, 2021 Mudrick Capital Management purchased Convertible Senior Secured Notes of an aggregate principal amount of £151,000 thousand ($200,000 thousand) for an aggregate purchase price of £145,000 thousand ($192,000 thousand). The Convertible Senior Secured Notes are initially convertible into up to 18,181,820 ordinary shares at an initial conversion rate of 90.9091 ordinary shares per £824 ($1,000). In accordance with IFRS 9, this is treated as a hybrid instrument and is designated it in entirety as fair value through profit or loss. The valuation methods and assumptions are shown in note 14. The Company has elected to pay interest in-kind at 9% per annum. Interest is paid semi-annually in arrears and on June 15, 2023 the Company authorised the payment of interest by increasing the nominal amount of the outstanding Convertible Senior Secured Notes by £7,963 thousand ($9,826 thousand). Several covenants exist including retention of $10 million cash. Accordingly, cash at bank includes £7,865 thousand retained for this purpose as at June 30, 2023. |
Financial instruments |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial instruments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial instruments | 14Financial instruments To provide an indication about the reliability of the inputs used in determining fair value, the Company classifies its financial instruments into the three levels prescribed under the accounting standards. Financial liabilities at fair value through profit and loss:
The fair value of financial instruments is deemed to be equivalent to the carrying value. Level 1: The fair value of financial instruments traded in active is based on quoted market prices at the end of the reporting period. As such, warrants issued but not exercised are valued with reference to the observable market price as at the period end date ($0.18 per warrant). Level 3: If one or more of the significant inputs is not based on observable market data, the instrument is included in level 3. This is the case for the issued Convertible Senior Secured Notes. The fair value of the convertible senior secured notes has been estimated using an option pricing model, in accordance with the International Valuation Standards definition of “market value”. The following inputs have been used:
No changes were made during the period ended June 30, 2023 to the valuation techniques applied as at December 31, 2022. For more information about the convertible senior secured notes, please refer to the Group’s annual financial statements for the year ended December 31, 2022. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial risk management and impairment of financial assets |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial risk management and impairment of financial assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial risk management and impairment of financial assets | 15Financial risk management and impairment of financial assets The Group’s activities expose it to a variety of financial risks including market risk, credit risk, foreign exchange risk and liquidity risk. Credit risk Credit risk is the risk of financial loss to the Group if a counterparty to a financial instrument fails to meet its contractual obligations, arising principally from prepayments to suppliers and deposits with the Group’s bank. Also included in Cash at bank is £7,865 thousand deemed to be restricted as at June 30, 2023. 15Financial risk management and impairment of financial assets (continued) The carrying amount of financial assets represents the maximum credit exposure. Therefore, the maximum exposure to credit risk at the balance sheet date was £1,811 thousand (December 31, 2022: £790 thousand) being the total of the carrying amount of financial assets, including contractual receivables but excluding R&D tax credits receivables and cash. The allowance account of trade receivables is used to record impairment losses unless the Group is satisfied that no recovery of the amount owing is possible; at that point the amounts considered irrecoverable are written off against the trade receivables directly. The Group provides for impairment losses based on estimated irrecoverable amounts determined by reference to specific circumstances and the experience of management of debtor default in the industry. On that basis, the loss allowance as at June 30, 2023 and December 31, 2022 was determined as £nil for trade receivables. Market risk Market risk is the risk that changes in market prices, such as foreign exchange rates, interest rates and equity prices will affect the Group’s financial position. The Group’s principal exposure to market risk is exposure to foreign exchange rate fluctuations. There are currently no currency forwards, options, or swaps to hedge this exposure. Foreign exchange risk The Group is exposed to foreign exchange risk arising from exposure to various currencies in the ordinary course of business. The Group received funding in USD, and subsequently holds cash in both USD and GBP. The majority of the Group’s trading costs are in GBP. The Group also has supply contracts denominated in USD and EUR. The Group holds sufficient cash in both USD and GBP to satisfy its trading costs in each of these currencies. The Company may be exposed to material foreign exchange risk in subsequent period as a result of the significance of the USD denominated Convertible Senior Secured Notes in particular relative to USD cash deposits held (which were $24,963 thousand at June 30, 2023) and which are expected to decline as expenses are incurred until future funding is secured. Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Group’s management uses short and long-term cash flow forecasts to manage liquidity risk. Forecasts are supplemented by sensitivity analysis which is used to assess funding adequacy for at least a 12-month period. The Company manages its cash resources to ensure it has sufficient funds to meet all expected demands as they fall due. 15Financial risk management and impairment of financial assets (continued) Maturity analysis
Capital management The Group’s objective when managing capital is to ensure the Group continues as a going concern; and grows in a sustainable manner. Given the ongoing development of eVTOL aircraft with minimal revenues, the Group relies on funding raised from the Business Combination transaction and other equity investors. Cash flow forecasting is performed on a regular basis which includes rolling forecasts of the Group’s liquidity requirements to ensure that the Group has sufficient cash to meet operational needs. |
Related party transactions |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||
| Related party transactions | |||||||||||||||||||||||||||||||||||||||||
| Related party transactions | 16Related party transactions Key management personnel compensation Key management personnel are the members of the Board.
Aggregate gains made on the exercise of share options for the Directors during the period totalled £8,156 thousand (June 30, 2022: £nil) Summary of transactions with other related parties During the period ending June 30, 2023 Imagination Industries Ltd, a company wholly and solely controlled by Stephen Fitzpatrick, charged the Group management fees of £42 thousand (2022: £nil) in relation to the provision of flexible desk and office space in London, of which £42 thousand was outstanding as at June 30, 2023 (2022: £nil). 16Related party transactions (continued) On April 21, 2023, the Board agreed to a succession plan, transitioning the chairperson of the Board during the course of 2023. Dómhnal Slattery has served as the Board’s chairperson since shortly following the Company’s listing on the New York Stock Exchange. As previously disclosed, in January 2022, the Company and Stephen Fitzpatrick entered into an option agreement with Mr. Slattery, pursuant to which Mr. Fitzpatrick granted Mr. Slattery an option to purchase up to an aggregate of 1,175,000 ordinary shares of the Company for an exercise price of $0.0001 per share. To date, Mr. Slattery has not exercised the Call Option. On April 21, 2023, Mr. Slattery, Mr. Fitzpatrick and the Company entered into an option termination agreement, pursuant to which the parties have agreed to terminate the Call Option in consideration for specified payments of up to an aggregate of $2.5 million to be paid by Mr. Fitzpatrick to Mr. Slattery, subject to certain conditions, including the Company raising additional funds during 2023, Mr. Slattery remaining in the role of chairperson through the Transition Date and the Company maintaining a minimum pre-order book. Following the termination of the Call Option, Mr. Fitzpatrick will continue to own the ordinary shares underlying the Call Option. A total of 18,750 immediately vesting nil cost options were granted to Non-Executive Directors during the period. Accordingly, share based payment charge of £55 thousand has been recognised (June 30, 2022: £nil) based on the prevailing share price on the date of issuance. During the period, Non-Executive Directors exercised a total of 5,613,287 options. On January 23, 2023, Michael Cervenka resigned from the Board of Directors. |
Events occurring after the reporting period |
6 Months Ended |
|---|---|
Jun. 30, 2023 | |
| Events occurring after the reporting period | |
| Events occurring after the reporting period | 17Events occurring after the reporting period On August 2, 2023 Mr. Slattery resigned as chairperson and director, and Mr. Flewitt was appointed as chairperson, in each case effective as of August 3, 2023. In connection with this, the option termination agreement referred to in note 16 was amended with effect from August 2, 2023, as a result of which the remaining payment is conditional only on the Company’s maintenance of a minimum pre-order book. Also as previously disclosed on July 3, 2023, the Company appointed Stuart Simpson as its new Chief Financial Officer, effective September 11, 2023. On August 2, 2023, Vincent Casey, who previously served as the Company’s CFO between November 2020 and February 2023 and who remained a director on the Board following his resignation as CFO, notified the Board of his resignation as a member of the Board, effective as of August 3, 2023. |
Significant accounting policies (Policies) |
6 Months Ended | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||
| Significant accounting policies | |||||||||||||||||||||||||||||||
| Basis of preparation | Basis of preparation This unaudited condensed consolidated interim financial report for the half-year reporting period ended 30 June 2022 has been prepared in accordance with International Financial Reporting Standards (IFRS) applicable to the preparation of interim financial statements, IAS 34 Interim Financial Reporting. The interim report does not include all the notes of the type normally included in an annual financial report. Accordingly, this report is to be read in conjunction with the annual report for the year ended 31 December 2022. The accounting policies adopted are consistent with those of the previous financial year. The unaudited condensed consolidated interim financial report has been prepared on a historical cost basis, as modified by the revaluation of certain financial assets and liabilities (including derivative financial instruments) which are recognized at fair value through profit and loss. Items included in the unaudited condensed consolidated interim financial report are measured using the currency of the primary economic environment in which the entity and its subsidiaries operate (‘the functional currency’). The financial information is presented in pounds sterling (‘£’ or ‘GBP’), which is the Group’s functional and presentation currency, and all amounts are presented in and rounded to the nearest thousand unless otherwise indicated. |
||||||||||||||||||||||||||||||
| Basis of consolidation | Basis of consolidation Vertical Aerospace Ltd is the parent of the Group. Details of the material subsidiaries are as follows:
All intercompany balances and transactions have been eliminated in consolidation. |
||||||||||||||||||||||||||||||
| Revision to comparative period for correction of immaterial error | Revision to comparative period for correction of immaterial error In connection with the preparation of the Group's condensed consolidated financial information for the six months period ended June 30, 2023, an error was identified in relation to the classification of foreign exchange rate changes in the statement of cash flows presented in the condensed consolidated financial information for the six months period ended June 30, 2022. An item of £4.6 million was incorrectly reported in the condensed consolidated statement of cash flows within adjustments to cash flows from non-cash items under Cash flows from operating activities instead of presenting it as effect of foreign exchange rate changes to reconcile the net increase or decrease in cash balances during the period. The correction of this matter will result in an increase in net cash flows used in operating activities of £4.6 million and an increase in effect of foreign exchange rate changes by £4.6 million. The revision has no impact on the condensed consolidated statement of financial position, statement of income and comprehensive income and statement of changes in equity. The Group has evaluated these amounts and has concluded that they should be corrected by revising the previously reported financial information when such amounts are presented for comparative purposes for the six months period ended June 30, 2023. |
||||||||||||||||||||||||||||||
| Going concern | Going concern Management has prepared a cashflow forecast for the Group and has considered the ability for the Group to continue as a going concern for the foreseeable future, being at least 12 months after approving this financial information. The Group is currently in the research and development phase of its journey to commercialize eVTOL technology. Commensurate with being in the development phase, the Group has invested heavily in research to support the development of its aircraft. The Group is not currently generating revenue and has incurred net losses and net cash outflows from operating activities since inception. As of June 30, 2023, the Group had £89.7 million of cash and cash equivalents held by the Company. Within the next 12 months following the date of this report, management expects the funding requirements to be approximately £80 million, which will be used primarily to fund the creation and testing of prototype aircraft. 2Significant accounting policies (continued) The Group will need to raise additional capital to fund its future operations and remain as a going concern, before the Group uses all of its existing resources. There can be no assurance that the Group will be able to obtain additional funding on acceptable terms and thus have sufficient funds to meet Group’s funding requirements. As a result, the timely completion of financing is important for the Group’s ability to continue as a going concern. The dependency on raising additional capital indicates that a material uncertainty exists that may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) on the Group’s ability to continue as a going concern and therefore the Group may be unable to realise the assets and discharge the liabilities in the normal course of business. The consolidated financial statements have been prepared assuming that the Group will continue as a going concern, which contemplates the continuity of operations, realisation of assets and the satisfaction of liabilities in the ordinary course of business and do not include any adjustments that would result if the Group were unable to continue as a going concern. |
||||||||||||||||||||||||||||||
| Changes in accounting policy | Changes in accounting policy A number of amended standards became applicable for the current reporting period. The group did not have to change its accounting policies or make retrospective adjustments as a result of adopting these amended standards: 1.IFRS 17 Insurance Contracts 2.Disclosure of Accounting Policies – Amendments to IAS 1 and IFRS Practice Statement 2 3.Definition of Accounting Estimates – Amendments to IAS 8 4.Deferred Tax related to Assets and Liabilities arising from a Single Transaction – Amendments to IAS 12 |
Significant accounting policies (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||
| Significant accounting policies | |||||||||||||||||||||||||||||||
| Summary of details of subsidiaries |
|
Other operating income (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||
| Other operating income | |||||||||||||||||||||||||||||||||||||||||
| Summary of analysis of the group's other operating income for the year |
|
Expenses by nature (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Expenses by nature | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of administrative, research and development expenses |
|
Finance income (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Finance Income. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of finance income |
|
Loss per share (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Loss per share | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of loss per share |
|
Trade and other receivables (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||
| Trade and other receivables | |||||||||||||||||||||||||||||||||||||||||
| Summary of trade and other receivables |
|
Share capital and other reserves (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share capital and reserves | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of allotted, called up and fully paid shares |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trade and other payables (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trade and other payables | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of trade and other payables | Amounts falling due within one year:
Amounts falling due after more than one year:
|
Warrant Liability (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | ||||||||||||||||||||||||||||||||||||
| Warrant Liability | ||||||||||||||||||||||||||||||||||||
| Schedule of warrants issued but not exercised |
|
|||||||||||||||||||||||||||||||||||
| Schedule of change in fair value of warrants | Recorded as a liability, the following shows the change in fair value during the period ended June 30, 2023:
|
Share-based payments (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based payments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of share-based payment transactions |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Two Thousand And Twenty One Incentive Award Plan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based payments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of movements in the number of share options |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EMI Scheme | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based payments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of movements in the number of share options |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative financial liabilities (Tables) |
6 Months Ended | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||
| Derivative financial liabilities | |||||||||||||||||||||||||
| Schedule of convertible senior secured notes |
|
Financial instruments (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial instruments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial liabilities at fair value through profit and loss: | Financial liabilities at fair value through profit and loss:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of fair value measurement inputs for valuation of convertible loan notes |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial risk management and impairment of financial assets (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial risk management and impairment of financial assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Maturity analysis |
|
Related party transactions (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||
| Key management personnel | |||||||||||||||||||||||||||||||||||||||||
| Related party transactions | |||||||||||||||||||||||||||||||||||||||||
| Key management personnel compensation |
|
Significant accounting policies - Basis of consolidation (Details) - GBP (£) £ in Thousands |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Dec. 31, 2022 |
|
| Significant accounting policies | |||
| Increase in net cash flows used in operating activities | £ (33,056) | £ (63,081) | |
| Effect of foreign exchange rate changes | £ (855) | 8,768 | |
| Correction of immaterial error | |||
| Significant accounting policies | |||
| Adjustments to cash flows from non-cash items | (4,600) | ||
| Increase in net cash flows used in operating activities | (4,600) | ||
| Effect of foreign exchange rate changes | £ 4,600 | ||
| VAGL | |||
| Significant accounting policies | |||
| Name of subsidiary | Vertical Aerospace Group Limited (“VAGL”) | ||
| Proportion of ownership interest and voting rights held | 100.00% | 100.00% | |
Significant accounting policies - Going concern (Details) - GBP (£) £ in Thousands |
Jun. 30, 2023 |
Dec. 31, 2022 |
Jun. 30, 2022 |
Dec. 31, 2021 |
|---|---|---|---|---|
| Significant accounting policies | ||||
| Cash and cash equivalents | £ 89,693 | £ 62,927 | £ 157,552 | £ 212,660 |
| Expected funding requirements over next 12-month period | £ 80,000 |
Other operating income (Details) - GBP (£) £ in Thousands |
6 Months Ended | |
|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
|
| Other operating income | ||
| Government grants | £ 1,874 | £ 1,214 |
| R&D tax relief | 13,971 | 2,193 |
| Other operating income | £ 15,845 | £ 3,407 |
Finance income (Details) - GBP (£) £ in Thousands |
6 Months Ended | |
|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
|
| Finance income | ||
| In-kind interest on convertible loan notes | £ (7,964) | £ (7,005) |
| Foreign exchange loss | (12,981) | |
| Interest expense on leases | (109) | (67) |
| Other | (67) | (10) |
| Total finance costs | (8,140) | (20,063) |
| Interest income on deposits | 1,704 | |
| Foreign exchange gain | 12,089 | |
| Fair value movements on convertible loan notes | 16,510 | 38,124 |
| Fair value movements on warrant liabilities | 2,030 | 4,373 |
| Total finance income | 32,333 | 42,497 |
| Total net finance income | £ 24,193 | £ 22,434 |
Loss per share (Details) - GBP (£) £ / shares in Units, £ in Thousands |
6 Months Ended | |
|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
|
| Loss per share | ||
| Net loss for the period, basic | £ (11,770) | £ (17,021) |
| Net loss for the period, diluted | £ (11,770) | £ (17,021) |
| Basic loss per share | £ (0.06) | £ (0.10) |
| Diluted loss per share | £ (0.06) | £ (0.10) |
| Weighted average issued shares, basic | 185,639,462 | 178,329,218 |
| Weighted average issued shares, diluted | 185,639,462 | 178,329,218 |
Trade and other receivables (Details) - GBP (£) £ in Thousands |
Jun. 30, 2023 |
Dec. 31, 2022 |
|---|---|---|
| Trade and other receivables | ||
| Government receivables | £ 10,247 | £ 10,905 |
| Prepayments | 7,669 | 7,169 |
| Other receivables | 1,811 | 790 |
| Total trade and other receivables | 19,727 | 18,864 |
| R&D tax credit receivable | £ 6,422 | £ 7,212 |
Share capital and other reserves - Allotted, called up and fully paid shares (Details) |
May 03, 2023
shares
|
Jun. 30, 2023
$ / shares
|
Jun. 30, 2023
GBP (£)
shares
|
Dec. 31, 2022
GBP (£)
shares
|
|---|---|---|---|---|
| Share capital and reserves | ||||
| Number of shares allotted, called up and fully paid shares | 221,211,021 | 214,211,021 | ||
| Share capital | £ | £ 16,517 | £ 15,952 | ||
| Number of shares issued | 7,000,000 | |||
| Ordinary Share | ||||
| Share capital and reserves | ||||
| Number of shares authorized | 500,000,000 | |||
| Par value per share | $ / shares | $ 0.0001 | |||
| Number of shares allotted, called up and fully paid shares | 221,211,021 | 214,211,021 | ||
| Share capital | £ | £ 16,517 | £ 15,952 |
Trade and other payables (Details) - GBP (£) £ in Thousands |
Jun. 30, 2023 |
Dec. 31, 2022 |
|---|---|---|
| Less than one year | ||
| Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items] | ||
| Trade payables | £ 4,645 | £ 4,454 |
| Accrued expenses | 5,325 | 10,500 |
| Social security and other taxes | 1,399 | 857 |
| Outstanding defined contribution pension costs | 279 | 220 |
| Total trade and other payables | 11,648 | 16,031 |
| After more than one year | ||
| Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items] | ||
| Deferred fees and charges | £ 3,933 | £ 4,153 |
Warrant Liability - Warrants were issued but not exercised (Details) - shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2023 |
Dec. 31, 2022 |
|
| Warrants | ||
| Outstanding, end of period | 19,264,935 | 19,264,935 |
| Public Warrants | ||
| Warrants | ||
| Outstanding, end of period | 15,264,935 | 15,264,935 |
| Mudrick Warrants | ||
| Warrants | ||
| Outstanding, end of period | 4,000,000 | 4,000,000 |
Warrant Liability - Change in fair value (Details) £ in Thousands |
6 Months Ended |
|---|---|
|
Jun. 30, 2023
GBP (£)
| |
| Warrant Liability | |
| Beginning balance | £ 4,961 |
| Change in fair value | 2,030 |
| Exchange differences on translation | (204) |
| Ending balance | £ 2,727 |
Warrant Liability - Additional information (Details) - Public Warrants |
6 Months Ended |
|---|---|
|
Jun. 30, 2023
D
$ / shares
shares
| |
| Warrants | |
| Redemption price | $ 0.01 |
| Trigger price | $ 18.00 |
| Threshold trading days for redemption of warrants | D | 20 |
| Threshold consecutive trading days for redemption of warrants | D | 30 |
| Number of shares entitled per public warrant | shares | 1 |
| Exercise price of warrants | $ 11.50 |
Share-based payments - Fair value of options granted (Details) - GBP (£) £ in Thousands |
6 Months Ended | |
|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
|
| Share-based payments | ||
| Total Expense Recognised | £ 7,056 | £ 7,294 |
| EMI Scheme | ||
| Share-based payments | ||
| Total Expense Recognised | 487 | 6,475 |
| 2021 Incentive Plan | ||
| Share-based payments | ||
| Total Expense Recognised | 6,513 | |
| Non-Executive Director awards | ||
| Share-based payments | ||
| Total Expense Recognised | £ 56 | |
| Suppliers and partners | ||
| Share-based payments | ||
| Total Expense Recognised | £ 819 | |
Derivative financial liabilities - Convertible Senior Secured Notes (Details) £ in Thousands |
6 Months Ended |
|---|---|
|
Jun. 30, 2023
GBP (£)
| |
| Financial liabilities | |
| Beginning balance | £ 143,918 |
| Ending balance | 122,394 |
| Convertible Senior Secured Notes | Mudrick | |
| Financial liabilities | |
| Beginning balance | 115,247 |
| Fair value movements | (16,510) |
| In-kind interest paid | 7,963 |
| Exchange differences on translation | (5,866) |
| Ending balance | £ 100,834 |
Derivative financial liabilities - Additional Information (Details) |
6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
|
Jun. 15, 2023
GBP (£)
|
Jun. 15, 2023
USD ($)
|
Dec. 16, 2021
GBP (£)
shares
|
Dec. 16, 2021
USD ($)
shares
|
Jun. 30, 2023
USD ($)
|
Jun. 30, 2023
GBP (£)
|
Dec. 16, 2021
USD ($)
shares
|
|
| Financial liabilities | |||||||
| Restricted cash | £ | £ 7,865,000 | ||||||
| Mudrick | Convertible Senior Secured Notes [Member] | |||||||
| Financial liabilities | |||||||
| Principal amount | £ 151,000,000 | $ 200,000,000 | |||||
| Aggregate purchase price | £ 145,000,000 | $ 192,000,000 | |||||
| Convertible shares | shares | 18,181,820 | 18,181,820 | |||||
| Conversion rate | shares | 90.9091 | 90.9091 | |||||
| Convertible senior secured notes principal amount, per instrument | £ 824 | $ 1,000 | |||||
| Increase in nominal amount of outstanding Convertible Senior Secured Notes | £ (7,963,000) | $ (9,826,000) | |||||
| Mandatory cash balance under loan covenants | $ | $ 10,000,000 | ||||||
| Restricted cash | £ | £ 7,865,000 | ||||||
| Mudrick | Convertible Senior Secured Notes [Member] | Interest paid in-kind and semi-annually in arrears | |||||||
| Financial liabilities | |||||||
| Interest rate | 9.00% | ||||||
Financial instruments - Financial liabilities at fair value through profit or loss (Details) £ in Thousands |
6 Months Ended | |
|---|---|---|
|
Jun. 30, 2023
GBP (£)
$ / shares
|
Dec. 31, 2022
GBP (£)
|
|
| Financial instruments | ||
| Carrying Value | £ 119,350 | £ 138,592 |
| Level 1 | Financial liabilities at fair value through profit and loss category | ||
| Financial instruments | ||
| Carrying Value | 2,727 | 4,961 |
| Level 3 | Financial liabilities at fair value through profit and loss category | ||
| Financial instruments | ||
| Carrying Value | 100,834 | 115,247 |
| Convertible Senior Secured Notes | ||
| Financial instruments | ||
| Carrying Value | 100,834 | 115,247 |
| Convertible Senior Secured Notes | Level 3 | Financial liabilities at fair value through profit and loss category | ||
| Financial instruments | ||
| Carrying Value | 100,834 | 115,247 |
| Warrant liabilities | Level 1 | Financial liabilities at fair value through profit and loss category | ||
| Financial instruments | ||
| Carrying Value | £ 2,727 | £ 4,961 |
| Value per warrant | $ / shares | £ 0.18 |
Financial instruments - Fair value of the convertible senior secured notes (Details) - Convertible Senior Secured Notes - Financial liabilities at fair value through profit and loss category - Level 3 |
Jun. 30, 2023 |
Dec. 31, 2022 |
|---|---|---|
| Risk-free rate | ||
| Financial instruments | ||
| Significant unobservable input liabilities | 0.044 | 0.041 |
| Dividend yield | ||
| Financial instruments | ||
| Significant unobservable input liabilities | 0 | 0 |
| Volatility | ||
| Financial instruments | ||
| Significant unobservable input liabilities | 80.0 | 65.0 |
| Credit spread | ||
| Financial instruments | ||
| Significant unobservable input liabilities | 27.50 | 26.38 |
Financial risk management and impairment of financial assets - Credit risk and impairment (Details) £ in Thousands, $ in Thousands |
Jun. 30, 2023
GBP (£)
|
Jun. 30, 2023
USD ($)
|
Dec. 31, 2022
GBP (£)
|
|---|---|---|---|
| Financial risk management and impairment of financial assets | |||
| Restricted cash | £ 7,865 | ||
| USD | |||
| Financial risk management and impairment of financial assets | |||
| Balances with banks | $ | $ 24,963 | ||
| Credit risk | |||
| Financial risk management and impairment of financial assets | |||
| Maximum exposure to credit risk | 1,811 | £ 790 | |
| Credit risk | Trade receivables | |||
| Financial risk management and impairment of financial assets | |||
| Allowance account for credit losses of financial assets | £ 0 | £ 0 |
Related party transactions - Key management personnel compensation (Details) - GBP (£) £ in Thousands |
6 Months Ended | |
|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
|
| Related party transactions | ||
| Salaries and other short term employee benefits | £ 460 | £ 629 |
| Payments to defined contribution pension schemes | 7 | 8 |
| Share-based payments | 56 | 79 |
| Key management compensation | £ 523 | £ 716 |
Related party transactions - Summary of transactions with other related parties (Details) $ / shares in Units, £ in Thousands, $ in Millions |
1 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jan. 31, 2022
$ / shares
shares
|
Jun. 30, 2023
GBP (£)
Options
|
Jun. 30, 2022
GBP (£)
|
Apr. 21, 2023
USD ($)
|
|
| Related party transactions | ||||
| Aggregate gain on directors' exercise of share options | £ 8,156 | £ 0 | ||
| Share based payment charge | 7,056 | 7,294 | ||
| Imagination Industries Ltd | ||||
| Related party transactions | ||||
| Services received, related party transactions | 42 | 0 | ||
| Amount outstanding | £ 42 | 0 | ||
| Mr. Slattery | Mr. Fitzpatrick | ||||
| Related party transactions | ||||
| Number of ordinary shares agreed to purchase upon call option | shares | 1,175,000 | |||
| Exercise price | $ / shares | $ 0.0001 | |||
| Aggregate amount agreed to pay | $ | $ 2.5 | |||
| Non executive directors | Nil cost options | ||||
| Related party transactions | ||||
| Options granted | Options | 18,750 | |||
| Share based payment charge | £ 55 | £ 0 | ||
| Options exercised | Options | 5,613,287 | |||